Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Equity

Contineum Therapeutics (CTNM) Return on Equity (2024 - 2025)

Historic Return on Equity for Contineum Therapeutics (CTNM) over the last 2 years, with Q3 2025 value amounting to 0.08%.

  • Contineum Therapeutics' Return on Equity rose 800.0% to 0.08% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.65% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Contineum Therapeutics reported Return on Equity of 0.08% as of Q3 2025, which was up 800.0% from 0.14% recorded in Q2 2025.
  • Contineum Therapeutics' Return on Equity's 5-year high stood at 0.08% during Q3 2025, with a 5-year trough of 0.44% in Q2 2024.